FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for metoprolol tartrate (generic beta-blocker), under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Myocardial Infarction

Drugs mentioned

• METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL TARTRATE (METOPROLOL TARTRATE)